Liao Mingjuan, Zhang Ying, Dufau Maria L
Program in Developmental Endocrinology and Genetics, National Institutes of Health, Bethesda, Maryland 20892-4510, USA.
Mol Endocrinol. 2008 Jun;22(6):1449-63. doi: 10.1210/me.2008-0035. Epub 2008 Mar 27.
LH receptor (LHR) gene transcription is subject to repression/derepression through various modes and multiple effectors. Epigenetic silencing and activation of the LHR is achieved through coordinated regulation at both histone and DNA levels. The LHR gene is subject to repression by deacetylation and methylation at its promoter region, where a HDAC/mSin3A repressor complex is anchored at Sp1 sites. The present studies revealed that protein kinase C (PKC) alpha/ERK signaling is important for the activation of LHR promoter activity, and the increase of endogenous transcripts induced by phorbol-12-myristate-13-acetate (PMA) in HeLa cells. Whereas these effects were attributable to PKCalpha activity, the ERK pathway was the downstream effector in LHR activation. PMA caused a significant enhancement of Sp1 phosphorylation at serine residue (s), which was blocked by PKCalpha or ERK inhibition. The interaction of activated phosphorylated ERK with Sp1 and ERK's association with the LHR promoter points to Sp1 as a direct target of ERK. After Sp1 phosphorylation, the HDAC1/mSin3A repressor complex dissociated from Sp1 sites, histone 3 was acetylated, and transcription factor II B and RNA polymerase II were recruited. In addition, overexpression of a constitutively active PKCalpha (PKCalpha CA) strongly activated LHR transcription in MCF-7 cells (devoid of PKCalpha), induced Sp1 phosphorylation at serine residue (s) and caused derecruitment of HDAC1/mSin3A complex from the promoter. These effects were negated by cotransfection of a dominant-negative PKCalpha. In conclusion, these studies have revealed a novel regulatory signaling mechanism of transcriptional control in which the LHR is derepressed through PKCalpha/ERK-mediated Sp1 phosphorylation, causing the release of HDAC1/mSin3A complex from the promoter.
促黄体生成素受体(LHR)基因转录通过多种方式和多种效应因子受到抑制/去抑制作用。LHR的表观遗传沉默和激活是通过组蛋白和DNA水平的协同调节实现的。LHR基因在其启动子区域通过去乙酰化和甲基化受到抑制,在该区域,一种组蛋白去乙酰化酶/ mSin3A抑制复合物锚定在Sp1位点。目前的研究表明,蛋白激酶C(PKC)α/细胞外信号调节激酶(ERK)信号对于LHR启动子活性的激活以及佛波醇-12-肉豆蔻酸酯-13-乙酸酯(PMA)在HeLa细胞中诱导的内源性转录本增加很重要。虽然这些效应归因于PKCα活性,但ERK途径是LHR激活中的下游效应因子。PMA导致Sp1丝氨酸残基处的磷酸化显著增强,这被PKCα或ERK抑制所阻断。活化的磷酸化ERK与Sp1的相互作用以及ERK与LHR启动子的结合表明Sp1是ERK的直接靶点。Sp1磷酸化后,组蛋白去乙酰化酶1(HDAC1)/ mSin3A抑制复合物从Sp1位点解离,组蛋白3被乙酰化,转录因子II B和RNA聚合酶II被招募。此外,组成型活性PKCα(PKCα CA)的过表达在MCF-7细胞(缺乏PKCα)中强烈激活LHR转录,诱导Sp1丝氨酸残基处的磷酸化,并导致HDAC1 / mSin3A复合物从启动子上解离。共转染显性负性PKCα可消除这些效应。总之,这些研究揭示了一种新的转录控制调节信号机制,其中LHR通过PKCα/ERK介导的Sp1磷酸化而被去抑制,导致HDAC1 / mSin3A复合物从启动子上释放。